Selank Protocol: Complete Cycling & Dosing Guide

Selank Protocol: Complete Cycling & Dosing Guide

DISCLAIMER: This guide is educational and informational only. Selank exists in a regulatory gray area in most Western countries—it is unscheduled but unapproved for medical use outside Russia and Ukraine. Consult a qualified healthcare provider before use. This content does not constitute medical advice, diagnosis, or treatment recommendations. Individual responses vary, and you are responsible for understanding local regulations and potential risks.

Overview

Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) derived from tuftsin, developed as an anxiolytic and nootropic agent. Unlike benzodiazepines, it modulates the GABAergic system without producing dependence or severe sedation. It also enhances BDNF expression, regulates serotonin metabolism, and exhibits immunomodulatory properties by inhibiting enkephalin-degrading enzymes.

Primary uses supported by evidence:

• Anxiety reduction and GAD management (Tier 3 evidence)
• Mild cognitive enhancement and nootropic effects (Tier 3 evidence)
• Stress resilience and mood support (Tier 3 evidence)
• Anti-inflammatory effects (Tier 2 evidence)
• Immune modulation (Tier 2 evidence)

Practical advantages:

• No abuse potential or physical dependence
• Favorable safety profile in clinical trials
• No cognitive blunting at therapeutic doses
• Cost-effective ($30–80/month)
• Available via intranasal and injection routes
• Effects persist 7+ days after final dose

Standard Protocol

Dosing Guidelines

Intranasal Administration:

• 250–500 mcg twice daily
• Typical starting dose: 250 mcg AM, 250 mcg PM
• Can titrate to 500 mcg per administration based on response

Injection (IM or SC):

• 250–500 mcg once or twice daily
• Same titration approach as intranasal
• Injections typically used for longer cycles (due to lower frequency convenience)

Cycle Structure

Standard 14-Day On / 14-Day Off Cycle

• Duration: 2 weeks on, 2 weeks off (most common for anxiety/cognition)
• Dosing: 250 mcg BID intranasal or 250–500 mcg daily injection
• Rationale: Allows assessment of effects, prevents tolerance buildup, and utilizes the 7+ day post-cycle benefit window

Extended 28-Day On / 14-Day Off Cycle

• Duration: 4 weeks on, 2 weeks off
• Dosing: 250 mcg BID for weeks 1–2; increase to 500 mcg BID for weeks 3–4 if well-tolerated
• Rationale: Better for deeper anxiety disorders or neurasthenia; requires monitoring for tolerance

Maintenance Micro-Cycle (Advanced Users)

• Duration: 5 days on / 9 days off, repeated
• Dosing: 250–500 mcg BID on-cycle
• Rationale: Minimizes tolerance; extends benefit window; used after baseline improvements achieved

Goal-Specific Protocols

Protocol A: Anxiety & GAD Management

Cycle: 14 days on / 14 days off (primary), or 28 days on / 14 days off (if severe)

Dosing Schedule:

• Days 1–3: 250 mcg AM + 250 mcg PM (intranasal)
• Days 4–14: 500 mcg AM + 250 mcg PM (if tolerated; reduce to 250+250 if side effects occur)

Expectation Timeline:

• Days 1–2: Mild sedation or emotional blunting possible; mild nasal irritation if intranasal
• Days 3–5: Anxiolytic effects begin; subtle calm without sedation
• Days 7–14: Pronounced anxiolytic effect; quality of life improvements reported
• Post-cycle (Days 15–28): Effects persist; anxiety remains reduced for 7+ days after final dose

Adjustment Triggers:

• If mild sedation persists beyond day 5, reduce to 250 mcg BID
• If no anxiolytic effect by day 7, increase to 500 mcg BID
• If emotional blunting occurs, reduce frequency to once daily or discontinue for 7 days

Protocol B: Cognitive Enhancement & Nootropic Use

Cycle: 14 days on / 21 days off (allows cognitive consolidation)

Dosing Schedule:

• Days 1–14: 250 mcg AM only (single daily dose for nootropic effect without oversedation)
• Alternatively: 250 mcg AM + 250 mcg PM if cognitive demands are high

Timing: Take in early morning to avoid afternoon/evening drowsiness

Expectation Timeline:

• Days 1–2: Mild mental fog or sluggishness possible
• Days 3–7: Subtle clarity; improved focus during cognitively demanding tasks
• Days 8–14: Mild nootropic effects evident; paired with reduced anxiety for better learning
• Post-cycle: Cognitive benefits plateau but anxiety reduction persists

Adjustment Triggers:

• If daytime sedation occurs, reduce to 250 mcg AM only
• If no cognitive shift by day 10, consider adding a second 250 mcg dose in early afternoon (pre-3 PM)
• Best results occur when combined with consistent sleep and stress management

Protocol C: Stress Resilience & Adaptogenic Use

Cycle: 28 days on / 14 days off (longer on-cycle for systemic stress adaptation)

Dosing Schedule:

• Weeks 1–2: 250 mcg AM + 250 mcg PM
• Weeks 3–4: 500 mcg AM + 250 mcg PM (optional; maintain previous dose if well-tolerated)

Timing: Split doses (morning and evening) to maintain steady-state stress buffering

Expectation Timeline:

• Days 1–3: Possible mild fatigue as stress response normalizes
• Days 5–10: Improved stress handling; less reactive cortisol surges
• Days 14–28: Pronounced stress resilience; workload tolerance increases; mood stability improves
• Post-cycle: Stress buffer remains elevated for 10–14 days; gradual decline over 3 weeks

Adjustment Triggers:

• If fatigue is bothersome, reduce to 250 mcg BID and reassess after 5 days
• If stress markers (heart rate variability, sleep quality) improve by week 2, maintain dose
• If no improvement by day 14, increase to 500 mcg BID

How to Administer Step-by-Step

Intranasal Administration

Materials Needed:

• Selank solution (typically 500 mcg/mL concentration from compounders)
• Sterile 1 mL tuberculin syringe with no needle (or spray bottle if provided)
• Sterile 0.9% saline solution (optional, for cleaning nares before use)

Steps:

1. Prepare: Ensure nostrils are clear. Gently rinse with warm saline if congested (optional but recommended).

2. Measure: Draw the required dose (0.5 mL for 250 mcg; 1 mL for 500 mcg) into the syringe.

3. Position: Sit upright or tilt head slightly back. Insert syringe tip into one nostril.

4. Administer: Press the plunger smoothly over 2–3 seconds. Keep head tilted for 30 seconds to allow absorption.

5. Alternate: If dosing both nostrils, repeat in the opposite nostril.

6. Wait: Rest for 5 minutes before lying down or vigorous activity. Avoid blowing nose for 5 minutes.

Frequency: Typically twice daily (AM and PM). Consistent timing improves steadiness of effect.

Injection Administration (IM or SC)

Materials Needed:

• Lyophilized Selank powder (typically 5 mg per vial)
• Sterile water for injection (bacteriostatic preferred for multi-dose vials)
• Sterile 1 mL insulin syringe (29–31 gauge) or larger syringe for initial reconstitution
• Alcohol prep pads
• Sterile gauze

Reconstitution Steps:

1. Calculate Volume: For 250 mcg dose from 5 mg vial:

   • 5 mg = 5,000 mcg
   • 250 mcg ÷ 5,000 mcg = 0.05 mL per dose
   • Reconstitute with 1 mL sterile water = 5 mg/mL concentration
   • 250 mcg dose = 0.05 mL

2. Prepare Vial: Swab rubber top with alcohol pad. Let dry 30 seconds.

3. Draw Water: Using a sterile syringe, draw 1 mL bacteriostatic water.

4. Inject: Insert needle into vial and inject water slowly. Do not shake; gently rotate vial until powder dissolves (typically 2–3 minutes).

5. Draw Dose: Once fully dissolved, draw back the plunger to create slight negative pressure. Insert needle and draw the required volume (0.05 mL for 250 mcg).

6. Store: If using multi-dose reconstitution, store in refrigerator (2–8°C) for up to 30 days.

Injection Steps:

1. Site Selection: Rotate between deltoid (shoulder), vastus lateralis (outer thigh), and abdomen to prevent lipodystrophy.

2. Prepare: Swab injection site with alcohol pad. Let dry 30 seconds.

3. Inject: Insert needle at 45–90-degree angle. Push plunger slowly (over 3 seconds) to minimize discomfort.

4. Withdraw: Remove needle and apply gentle pressure with sterile gauze for 10 seconds.

5. Frequency: Typically once daily at same time each morning for convenience.

Cycle Example: Week-by-Week Schedule (14-Day Anxiety Protocol)

What to Expect: Timeline of Effects

Early Adaptation Phase (Days 1–5)

Common:

• Mild sedation or drowsiness (particularly evening dose)
• Transient nasal irritation if intranasal (mild burning, slight congestion)
• Headache (mild, self-resolving within hours)
• Possible emotional blunting or flattened affect
• Fatigue or lethargy (especially early AM)

When to Adjust:

• If sedation is bothersome by day 3, reduce evening dose to 250 mcg
• If nasal irritation persists, switch to injection or rinse nares with saline post-administration
• If headache occurs, increase hydration and reduce dose by 50 mcg

Active Efficacy Phase (Days 6–14)

Expected:

• Anxiolytic effects emerge (typically by day 5–7)
• Baseline anxiety decreases noticeably
• Stress reactivity diminishes; less emotional volatility
• Mild nootropic effect (improved focus, clearer thinking without sedation)
• Sleep quality may stabilize if anxiety-driven insomnia was present
• Emotional blunting resolves if it occurred early; affect normalizes

Signs It's Working:

• Reduced intrusive thoughts or worry cycles
• Improved ability to engage in social settings without tension
• Lower resting heart rate or improved heart rate variability
• Better emotional regulation during stressful events
• Quality of life assessment improves

Post-Cycle Benefit Window (Days 15–28)

Characteristic:

• Anxiolytic effects persist 7–14 days after final dose
• Anxiety gradually returns to pre-cycle baseline by day 21–28
• No withdrawal symptoms or rebound anxiety
• Cognitive clarity may persist longer than anxiolytic effect

Common Protocol Mistakes

1. Dosing Too High Too Fast

• Error: Starting at 500 mcg BID or jumping dose escalations without assessment
• Consequence: Excessive sedation, emotional blunting, discouragement
• Fix: Begin at 250 mcg BID; increase only after 3–5 days if needed

2. Insufficient Cycle Length

• Error: Taking Selank for 3–5 days and expecting full anxiolytic effect
• Consequence: Minimal noticeable benefit; false perception of inefficacy
• Fix: Commit to minimum 14-day on-cycle; most benefit emerges by days 7–10

3. No Rest Periods

• Error: Running continuous cycles without 14+ day breaks
• Consequence: Potential tolerance buildup (though rare); reduced efficacy over months
• Fix: Always incorporate 14–21 day rest periods between cycles; use post-cycle benefit window

4. Wrong Route for Goal

• Error: Using intranasal when rapid systemic effect is needed (preference); using injection for acute PRN use (inconvenient)
• Consequence: Suboptimal timing; reduced compliance
• Fix: Use intranasal for flexibility and BID dosing; use injection for once-daily convenience on extended cycles

5. Inconsistent Timing

• Error: Taking doses at random times throughout the day
• Consequence: Unpredictable effects; difficult to assess true benefit
• Fix: Lock in AM dose (e.g., 7 AM) and PM dose (e.g., 7 PM); consistency matters

6. Inadequate Storage

• Error: Storing reconstituted solution at room temperature or in direct sunlight
• Consequence: Peptide degradation; reduced potency
• Fix: Refrigerate reconstituted vials (2–8°C); store lyophilized powder in cool, dark place or freezer

7. Stacking Without Rationale

• Error: Combining Selank with multiple anxiolytics (benzodiazepines, alcohol) without medical guidance
• Consequence: Unpredictable interactions; excessive sedation
• Fix: Use Selank as monotherapy during initial cycles; consider stacking only with non-CNS-depressant compounds (see stacking section)

How to Stack with Other Compounds

Synergistic Combinations

Selank + Magnesium (glycinate or threonate)

• Rationale: Magnesium enhances GABA-A receptor function; complements Selank's anxiolytic pathway
• Dosing: 300–500 mg magnesium glycinate daily; take separate from Selank by 2+ hours
• Benefit: Modest additive anxiety reduction; improved sleep quality
• Caution: May increase sedation; start with lower magnesium dose

Selank + L-Theanine

• Rationale: Theanine increases GABA and serotonin; different mechanism but complementary anxiolytic effect
• Dosing: 100–200 mg L-theanine daily (can be taken same time as Selank)
• Benefit: Enhanced calm; non-sedating; improved focus
• Caution: Minimal risk; safe combination

Selank + Omega-3 Fatty Acids (Fish Oil or Algae)

• Rationale: Omega-3s support BDNF expression (Selank's mechanism) and reduce inflammation
• Dosing: 2–3 g EPA/DHA daily
• Benefit: Enhanced neuroprotective effect; supports mood stability
• Caution: Mild blood-thinning effects; avoid if on anticoagulants

**